Tolterodine

Routes
Oral (PO)
Half-Life (t½)
PO: 2h
Formula
C22H31NO
Molecular Weight
325.49 g/mol
PubChem CID
443879
Aliases
Detrol

Pharmacological Mechanism

Bladder-preferential M3 muscarinic antagonist — designed for higher detrusor selectivity vs salivary gland. Active 5-OH metabolite via CYP2D6. Slightly cleaner anticholinergic profile than oxybutynin, but still meaningful Beers-list concerns.

Half-Life & Elimination Curve (PO: 2h)

100%50%25%12.5%0%0h0×t½2h1×t½4h2×t½6h3×t½8h4×t½10h5×t½0×t½ (0h): 100% remaining (~3.72 µg/L)1×t½ (2h): 50% remaining (~1.86 µg/L)2×t½ (4h): 25% remaining (~0.93 µg/L)3×t½ (6h): 12.5% remaining (~0.465 µg/L)4×t½ (8h): 6.3% remaining (~0.233 µg/L)5×t½ (10h): 3.1% remaining (~0.116 µg/L)
Plasma (PO)t½ Decay (2h)Effect Site (ke0)
  • 0×t½0h100% (3.72 µg/L)
  • 1×t½2h50% (1.86 µg/L)
  • 2×t½4h25% (0.93 µg/L)
  • 3×t½6h12.5% (0.465 µg/L)
  • 4×t½8h6.3% (0.233 µg/L)
  • 5×t½10h3.1% (0.116 µg/L)
Elimination t½2h (PO)
Rate Constant (ke)0.347 h⁻¹
Time to Peak (Tmax)1.39h
Est. Peak (Cmax)3.72 µg/L
Clearance (CL)39.2 L/h
97% Washout (5×t½)10h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References